Infinity Pharmaceuticals, Inc.
Heterocyclic compounds and uses thereof

Last updated:

Abstract:

Trisubstituted bicyclic heterocyclic compounds (e.g., pyridopyrimidinones) and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.

Status:
Grant
Type:

Utility

Filling date:

1 Mar 2019

Issue date:

9 Mar 2021